The Department of Dermatology at Yale, one of the oldest in the country, is deeply rooted in research and has grown to become the largest provider of specialized dermatologic care in the region.
The clinical research efforts of Yale dermatologists contributed significantly to the treatment of lethal skin tumors such as melanomas and cutaneous T-cell lymphomas. At present, we are actively exploring the uses of new technology such as photopheresis, a therapy for life-threatening and debilitating diseases like cutaneous T-cell lymphoma and graft versus host disease.
Our services are often the only hope for patients with resistant dermatologic illness that can affect the whole skin surface and demoralize the patient and family. We are widely recognized for our strength in the clinical areas of cutaneous lymphoma, melanoma, inherited disorders of keratinization, and keratinocyte carcinomas.
Our Dermatologic Surgery Unit uses advanced surgical and laser techniques to treat skin cancer and other skin tumors. In addition, our community outreach program brings the benefits of early cancer diagnosis to those for whom it might not otherwise be accessible